blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1081132

EP1081132 - HYDROXAMIC ACID DERIVATIVES AND MEDICINAL UTILIZATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.01.2005
Database last updated on 23.04.2024
Most recent event   Tooltip21.03.2008Lapse of the patent in a contracting state
New state(s): PT		published on 23.04.2008  [2008/17]
Applicant(s)For all designated states
Mitsubishi Pharma Corporation
6-9, Hiranomachi 2-chome, Chuo-ku Osaka-shi
Osaka 541-0046 / JP
[N/P]
Former [2002/05]For all designated states
Mitsubishi Pharma Corporation
6-9, Hiranomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-0046 / JP
Former [2001/10]For all designated states
Welfide Corporation
6-9, Hiranomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-0046 / JP
Inventor(s)01 / GOTOU, Tomokazu, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
02 / TAKEDA, Shinji, Welfide Corp.Drug Development Lab.
955, Oaza-Koiwai, Yoshitomimachi
Chikujo-gun, Fukuoka 871-8550 / JP
03 / MAEDA, Kazuhiro, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
04 / YOSHIDA, Tomohiro, Welfide Corp.Drug Discovery Lab
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
05 / SUGIYAMA, Naoki, Welfide Corp. Drug Discovery Lab.
7-25, Koyata 3-chome, Iruma-shi
Saitama 358-0026 / JP
06 / TAKEMOTO, Tadahiro, Welfide Corp. Drug Disc. Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
 [2004/22]
Former [2004/19]01 / GOTOU, Tomokazu, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
02 / TAKEDA, Shinji, Welfide Corp.Drug Development Lab.
955, Oaza-Koiwai, Yoshitomimachi
Chikujo-gun, Fukuoka 871-8550 / JP
03 / MAEDA, Kazuhiro, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
04 / YOSHIDA, Tomohiro, Welfide Corp.Drug Discovery Lab
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
05 / SUGIYAMA, Naoki, Welfide Corp. Drug Discovery Lab.
7-25, Koyata 3-chome,Iruma-shi
Saitama 358-0026 / JP
06 / TAKEMOTO, Tadahiro, Welfide Corp. Drug Disc. Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
Former [2001/10]01 / GOTOU, Tomokazu, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
02 / TAKEDA, Shinji, Welfide Corp.Drug Development Lab.
955, Oaza-Koiwai, Yoshitomimachi
Chikujo-gun, Fukuoka 871-8550 / JP
03 / MAEDA, Kazuhiro, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
04 / YOSHIDA, Tomohiro, Welfide Corp.Drug Discovery Lab
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
05 / SUGIYAMA, Naoki, Welfide Corp. Drug Discovery Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
06 / TAKEMOTO, Tadahiro, Welfide Corp. Drug Disc. Lab.
25-1, Shodaiohtani 2-chome
Hirakata-shi, Osaka 573-1153 / JP
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2001/10]von Kreisler, Alek, Dipl.-Chem., et al
Patentanwälte, von Kreisler-Selting-Werner, Bahnhofsvorplatz 1 (Deichmannhaus)
50667 Köln / DE
Application number, filing date99921188.119.05.1999
[2001/10]
WO1999JP02631
Priority number, dateJP1998014130422.05.1998         Original published format: JP 14130498
[2001/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9961412
Date:02.12.1999
Language:EN
[1999/48]
Type: A1 Application with search report 
No.:EP1081132
Date:07.03.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.1999 takes the place of the publication of the European patent application.
[2001/10]
Type: B1 Patent specification 
No.:EP1081132
Date:10.03.2004
Language:EN
[2004/11]
Search report(s)International search report - published on:JP02.12.1999
(Supplementary) European search report - dispatched on:EP01.10.2002
ClassificationIPC:C07C259/06, C07C233/31
[2001/10]
CPC:
C07D209/48 (EP,US); C07C259/06 (EP,KR,US); A61P19/02 (EP);
C07D209/46 (EP,US); C07D233/72 (EP,US); C07D307/52 (EP,US);
C07D309/12 (EP,US); C07D405/12 (EP,US); C07D405/14 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/10]
TitleGerman:HYDROXAMSÄUREDERIVATE UND IHRE MEDIZINISCHE ANWENDUNG[2001/10]
English:HYDROXAMIC ACID DERIVATIVES AND MEDICINAL UTILIZATION THEREOF[2001/10]
French:DERIVES D'ACIDE HYDROXAMIQUE ET UTILISATION MEDICINALE DE CES DERIVES[2001/10]
Entry into regional phase13.12.2000Translation filed 
13.12.2000National basic fee paid 
13.12.2000Search fee paid 
13.12.2000Designation fee(s) paid 
13.12.2000Examination fee paid 
Examination procedure17.12.1999Request for preliminary examination filed
International Preliminary Examining Authority: JP
13.12.2000Examination requested  [2001/10]
10.12.2002Amendment by applicant (claims and/or description)
27.08.2003Communication of intention to grant the patent
30.12.2003Fee for grant paid
30.12.2003Fee for publishing/printing paid
Opposition(s)13.12.2004No opposition filed within time limit [2005/09]
Fees paidRenewal fee
30.05.2001Renewal fee patent year 03
28.05.2002Renewal fee patent year 04
27.05.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT10.03.2004
BE10.03.2004
CH10.03.2004
CY10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
IE19.05.2004
LU19.05.2004
MC31.05.2004
DK10.06.2004
GR10.06.2004
SE10.06.2004
PT10.08.2004
[2008/17]
Former [2007/22]AT10.03.2004
BE10.03.2004
CH10.03.2004
CY10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
IE19.05.2004
LU19.05.2004
MC31.05.2004
DK10.06.2004
GR10.06.2004
SE10.06.2004
Former [2005/24]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
IE19.05.2004
LU19.05.2004
MC31.05.2004
DK10.06.2004
GR10.06.2004
SE10.06.2004
Former [2005/23]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
LU19.05.2004
MC31.05.2004
DK10.06.2004
GR10.06.2004
SE10.06.2004
Former [2005/18]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
MC31.05.2004
DK10.06.2004
GR10.06.2004
SE10.06.2004
Former [2005/11]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
MC31.05.2004
GR10.06.2004
SE10.06.2004
Former [2005/05]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
NL10.03.2004
GR10.06.2004
SE10.06.2004
Former [2005/01]AT10.03.2004
BE10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
GR10.06.2004
SE10.06.2004
Former [2004/44]AT10.03.2004
CH10.03.2004
FI10.03.2004
LI10.03.2004
GR10.06.2004
SE10.06.2004
Former [2004/43]AT10.03.2004
FI10.03.2004
GR10.06.2004
SE10.06.2004
Former [2004/41]FI10.03.2004
GR10.06.2004
SE10.06.2004
Former [2004/40]FI10.03.2004
SE10.06.2004
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]JPH08505605  ;
 [AP]WO9830541  (ABBOTT LAB [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.